Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Bupropion Extended Release Oral Tablet
BRIGHT MINDS BIOSCIENCES INC.
Postpartum Smoking Relapse
1 trial -
CAPECITABINE, CALCIUM FOLINATE, KEYTRUDA 25 mg/mL concentrate for solution for infusion, Calciumfolinat Kabi 10 mg/ml Injektions-/Infusionslösung, FLUOROURACIL, Lenvatinib, Lenvatinib, Calciumfolinat-GRY® 100 mg/10 ml Injektionslösung, OXALIPLATIN, Lenvatinib, CALCIUM LEVOFOLINATE , CAPECITABINE
Merck Sharp and Dohme
Advanced/Metastatic Gastroesophageal Adenocarcinoma
1 trial -
CEFEPIME, TEICOPLANIN, METRONIDAZOLE, METRONIDAZOLE, MEROPENEM, TAZOBACTAM, VANCOMYCIN, LEVOFLOXACIN, CIPROFLOXACIN, CEFTAZIDIME, METRONIDAZOLE, CIPROFLOXACIN, LEVOFLOXACIN, AMIKACIN, CIPROFLOXACIN, PIPERACILLIN
The George Institute
Infectious diseases
1 trial -
CELLULOSE, MICROCRYSTALLINE, Diltiazem HCl Auro retard 120 mg, tabletten met gereguleerde afgifte
Disc Medicine
Angina
1 trial -
CELLULOSE, MICROCRYSTALLINE, YOCORAL 5 mg tabletten, Hydrocortison Teva 10 mg, filmomhulde tabletten
Disc Medicine
Mimic an acute stress response in humans.
1 trial -
CHLORURE DE SODIUM 0,9 % VIAFLO, solution pour perfusion, Avastin 25 mg/ml concentrate for solution for infusion.
Tour Hekla
1st line treatment for unresectable metastatic colorectal cancer
1 trial -
COLECALCIFEROL , The Placebo product consists only of pure Ph. Eur. refined olive and it differs from Test product for the absence of active substance only: therefore, there are no reasons to suspect that the placebo product will undergo changes in its physical characteristics or degradation., Placebo
Fondazione Telethon ETS
obese elderly people with vitamin D deficiency
1 trial -
CSII
The First People's Hospital of Lianyungang
Diabetes Mellitus, Type 2
1 trial -
Calquence 100 mg film-coated tablets, Calquence 100 mg film-coated tablets
AstraZeneca AB
Chronic Lymphocytic Leukaemia and Moderate to Severe Cardiac Impairment
1 trial -
Camrelizumab + chemotherapy+Thalidomide
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Cancer
1 trial -
Cannabidiol
Jazz Pharmaceuticals Ireland Limited
Lennox Gastaut Syndrome
1 trial -
Cannabidiol (Epidiolex)
Jazz Pharmaceuticals Ireland Limited
Study the Efficacy of Epidiolex for Typical Absence Seizures
1 trial -
Cannabidiol Oral Solution [Epidiolex]
Jazz Pharmaceuticals Ireland Limited
Tuberous Sclerosis Complex Associated Neuropsychiatric Disease
1 trial -
Capsules with microcrystalline cellulose, Colchicine Teva 0,5 mg, tabletten
Disc Medicine
Type 1 Diabetes
1 trial -
Carvedilol NORMON 6.25 mg tablets EFG., Il n'a pas de substance active. Le produit est un comprimé pelliculé sécable blanc, de forme ovale, de longueur 8mm, avec une gravure F57 sur une face et une barre de sécabilité sur l’autre face. Excipients: Prosolv Easytab SP (Cellulose microcristalline, Silice colloïdale, Sodium starch glycolate, Sodium stéaryl fumarate). Solution de pelliculage: (Hypromellose, PEG 3350, Candurin silver sheen)
Tour Hekla
Asymptomatic Child-Pugh A5 to B8 cirrhosis
1 trial -
Cefecin Tab.
United Therapeutics Europe Ltd
Acute Sinusitis
1 trial -
Ceftriaxon Fresenius Kabi 1 g poeder voor oplossing voor injectie of infusie, Ceftazidim Fresenius Kabi 500 mg poeder voor oplossing voor injectie, Amoxicilline/Clavulaanzuur Sandoz 2000 mg/200 mg i.v., poeder voor oplossing voor intraveneuze infusie, Cefuroxim Hikma 1500 mg poeder voor oplossing voor injectie of infusie, Meropenem CF 1000 mg, poeder voor oplossing voor injectie of infusie, Meropenem Fresenius Kabi 1 g poeder voor oplossing voor injectie of infusie, Piperacilline/Tazobactam Fresenius Kabi 2
Disc Medicine
Sepsis
1 trial -
Celestone Cronodose suspensión inyectable, Plasma rich in growth factors
Wuhan Createrna Science and Technology Co., Ltd
Low back pain
1 trial -
Chemoembolization and Response-Dependent Resection
The First People's Hospital of Lianyungang
Resectable Hepatocellular Carcinoma Beyond Milan Criteria
1 trial -
Colquhounia Root Tablet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Rheumatoid Arthritis
1 trial -
Commercial Hylenex® recombinant (hyaluronidase human injection)
HALOZYME THERAPEUTICS, INC.
Type 1 Diabetes Mellitus
1 trial -
Crushed ticagrelor followed by morphine
COLLEGIUM PHARMACEUTICAL, INC
Unstable Angina Pectoris
2 trials -
Crysvita (burosumab-twza) Treatment
Ultragenyx UK Limited
Epidermal Nevus Syndrome
1 trial -
Cymbalta 30 mg hard gastro-resistant capsules, Vimpat 50 mg film-coated tablets
Disc Medicine
chemotherapy-induced neuropathic pain
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources